Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response
Transcriptomics Dataset
FAIR Metrics
0 evaluations
General Information
| Accession | GSE38376 |
| Title | Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response |
| Description | Analysis of lapatinib-resistant ErbB2-positive cells treated with 0.1 or 1 uM lapatinib. Lapatinib is an EGFR/ErbB2 inhibitor used to treat ErbB2positive advanced or metastatic breast cancer. Results provide insight into the mechanisms underlying the development of resistance to lapatinib. |
| Landing Page | https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38376 |
| Repository | Gene Expression Omnibus |
Tools
used to analyze the dataset
Canned Analyses
generated with the dataset
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.
